Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 1, 2014
Pharmacy Choice - News - U.S. Pharmaceutical Industry - October 1, 2014

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/1/14 - "Apparatus for Repairing Bone Defects" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors BERELSMAN, Brian K.; MAXSON, William; Robert, Paul, filed on May 19, 2014, was made available online on September 18, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Biome
10/1/14 - "Compounds Targeting the Cell Invasion Protein Complex, Their Pharmaceutical Compositions and Methods of Use Thereof" in Patent Application Approval...
"Compounds Targeting the Cell Invasion Protein Complex, Their Pharmaceutical Compositions and Methods of Use Thereof" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors Alaoui-Jamali, Moulay A.; Bijian, Krikor; Tao, Jiang, filed on October 26, 2012, was made available
10/1/14 - Alnylam Strengthens Management Team with New Key Appointments
By a News Reporter-Staff News Editor at Biotech Week Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced the expansion of its management team with the appointments of Karen Anderson as Senior Vice President, Chief Human Resources Officer; Laurie Keating as Senior Vice President, General Counsel, and Secretary; and Marko
10/1/14 - Auxilium Pharmaceuticals, Inc. Presents XIAFLEX CCH Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting
By a News Reporter-Staff News Editor at Biotech Week Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced the first presentation of positive safety and efficacy data from the AUX-CC-867 MULTICORD Phase 3 b study. These data will be presented at the 69 Annual Meeting of the American Society for Surgery of the Hand being
10/1/14 - Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease
By a News Reporter-Staff News Editor at Biotech Week Avanir Pharmaceuticals, Inc. announced positive results from its phase II clinical trial evaluating the safety and efficacy of AVP-923 for the treatment of agitation in patients with Alzheimer's disease. "This is an exciting advancement in Alzheimer's disease research," said Jeffrey Cummings,
10/1/14 - DGAP-News: ERYTECH reports positive top-line Phase III results from clinical study with GRASPA(R) in Acute Lymphoblastic Leukemia
DGAP-News: ERYTECH PHARMA SA/ Key word: Study results ERYTECH reports positive top-line Phase III results from clinical study with GRASPA (R) in Acute Lymphoblastic Leukemia 01.10. 2014/ 09:30- ERYTECH reports positive top-line Phase III results from clinical study with GRASPA (R)
10/1/14 - Drug company payments to SC physicians detailed [The State (Columbia, S.C.)]
"Just like we want to know who's paying our elected officials, we want to know who pays our doctors," said Tony Keck, director of the S.C. Department of Health and Human Services and a fan of transparency in health care funding. In fact, his agency uses the same concept, paying higher or lower Medicaid rates for some procedures to influence doctors
10/1/14 - FDA Approves Baxter's RIXUBIS [Coagulation Factor IX Recombinant] for Treatment of Children with Hemophilia B
By a News Reporter-Staff News Editor at Biotech Week Baxter International Inc. announced that the United States Food and Drug Administration has approved RIXUBIS for routine prophylactic treatment, control and prevention of bleeding episodes, and perioperative management in children with hemophilia B. RIXUBIS was the first recombinant factor IX..
10/1/14 - Fee for Using a Rare Pediatric Disease Priority Review Voucher in Fiscal Year 2015
SUMMARY: The Food and Drug Administration is announcing the fee rate for using a rare pediatric disease priority review voucher for fiscal year 2015. The Federal Food, Drug, and Cosmetic Act, as amended by the Food and Drug Administration Safety and Innovation Act, authorizes FDA to determine and collect rare pediatric disease priority review user
10/1/14 - Filing an IND for a Phase II Study, ITI is Moving Closer to Solutions for Allergy
DNA Vaccine pioneer Immunomic Therapeutics, Inc., a privately held biotechnology company, submitted a new Investigational New Drug Application to the FDA on September 10th. ITI plans to use the results from this study, which will take place in Japan, to support future clinical studies in the United States. As a result of submitting IND for the Phas
10/1/14 - Gilead Sciences Updates on European CHMP [Manufacturing Close - Up]
Gilead Sciences reported that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has adopted a positive opinion on the company's Marketing Authorization Application for Harvoni. The CHMP's recommendation will now be reviewed by the European Commission, which has the authority to approve...
10/1/14 - Johnson & Johnson Announces Agreement To Acquire Alios BioPharma; Acquisition Strengthens Existing Pipeline in Viral Diseases
Release date- 30092014- NEW BRUNSWICK, N.J- Johnson& Johnson today announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash. 'We are excited that this acquisition will enable us to explore t
10/1/14 - Key Stakeholders in the Healthcare Ecosystem to Attend the Inaugural FDA/CMS Summit for Payers
By a News Reporter-Staff News Editor at Biotech Week IIR announced the FDA/ CMS Summit for Payers, a new event dedicated to forging collaboration between the key stakeholders in the rapidly evolving healthcare ecosystem. The FDA/ CMS Summit for Payers will bring together leaders from the Food& Drug Administration, Centers for Medicare& Medicaid S
10/1/14 - Kolltan Pharmaceuticals, Inc. Files Registration Statement for Proposed Initial Public Offering
By a News Reporter-Staff News Editor at Biotech Week Kolltan Pharmaceuticals, Inc. announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. Leerink Partners and Stifel are acting as joint book-running managers for the off
10/1/14 - Medrio and RPM Alliance join forces
Medrio, a leading provider of eClinical Software as a Service for clinical research, announced today that RPM Alliance, providers of clinical research and data management services to biotech and pharmaceutical companies, have joined Medrio's Partner Program. "We are delighted to add RPM Alliance to our Partner Program," says Scott Weidley, VP of S
10/1/14 - New Clinical Trials and Studies Study Findings Have Been Reported by Investigators at Merck & Company (Costs of Adult Vaccination in Medical...
New Clinical Trials and Studies Study Findings Have Been Reported by Investigators at Merck& Company. According to news reporting originating from Philadelphia, Pennsylvania, by NewsRx correspondents, research stated, "Community pharmacies are a convenient setting for vaccinating adults against infectious diseases in the United States.
10/1/14 - Obamacare Sunshine Act sheds light on $3.5B paid to doctors [Chicago Tribune]
Oct. 01 U.S. doctors and teaching hospitals received nearly $3.5 billion from pharmaceutical companies and medical device manufacturers over the last five months of 2013, according to a partial set of data released Tuesday by the federal government. The data include 4.4 million payments and other transfers of value by drug- and device-makers to s
10/1/14 - OnCore Biopharma Agrees to Acquire Enantigen Therapeutics
Through the acquisition, OnCore will assume development of Enantigen's two novel discovery programs, one targeting inhibition of s-antigen secretion and one targeting capsid assembly inhibition. "We believe that OnCore is in the best position to rapidly advance our programs into human clinical trials, and we look forward to joining the OnCore rese
10/1/14 - Patent Application Titled "Composition for Treatment of Inflammatory Disorders" Published Online
By a News Reporter-Staff News Editor at Biotech Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventor Metselaar, Josbert Maarten, filed on May 27, 2014, was made available online on September 18, 2014. The assignee for this patent application is Enceladus Pharmaceuticals B.
10/1/14 - Patent Application Titled "Nutritional Formulations Including Human Milk Oligosaccharides and Antioxidants and Uses Thereof" Published Online
By a News Reporter-Staff News Editor at Biotech Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors BUCK, RACHAEL; DUSKA-MCEWEN, GERALYN O.; SCHALLER, JOSEPH P., filed on March 4, 2014, was made available online on September 18, 2014. The assignee for this patent applica
10/1/14 - Patent Issued for Compounds Having Analgesic And/Or Immunostimulant Activity
By a News Reporter-Staff News Editor at Biotech Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Leblond, Bertrand; Beausoleil, Eric; Taverne, Thierry; Donello, John E., filed on March 1, 2012, was published online on September 16, 2014. The patent's assignee for patent number 8835463 is Allergan, Inc.. New
10/1/14 - Patent Issued for Derivatives of 1-(2-Halo-Biphenyl-4-Yl)-Alkanecarboxylic for the Treatment of Neurodegenerative Diseases
By a News Reporter-Staff News Editor at Biotech Week According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Imbimbo, Bruno Pietro; Raveglia, Luca, filed on April 3, 2013, was published online on September 16, 2014. The assignee for this patent, patent number 8835494, is Chiesi Farmaceut
10/1/14 - Patent Issued for Isoxazolidine Derivatives
By a News Reporter-Staff News Editor at Biotech Week According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Ghidini, Eleonora; Capelli, Anna Maria, filed on March 15, 2012, was published online on September 16, 2014. The assignee for this patent, patent number 8835412, is Chiesi Farmace
10/1/14 - Patent Issued for Lipopeptide Compositions and Related Methods
By a News Reporter-Staff News Editor at Biotech Week A patent by the inventors O'Connor, Sandra; Sun, Sophie; Naik, Gaauri, filed on November 23, 2010, was published online on September 16, 2014, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 8835382 is assigned to Cubist Pharmaceuticals
10/1/14 - Patent Issued for Methods for Detecting Protein in Plasma
By a News Reporter-Staff News Editor at Biotech Week Glaxosmithkline LLC has been issued patent number 8835381, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Citerone, David Richard; Hottenstein, Charles Scott; Kehler, Jonathan R.. This patent was filed on June 12, 2008 and was
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

The Diversion of Controlled Substances and the Law
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415